dr. shuch on biology of non-clear cell rcc
Published 7 years ago • 254 plays • Length 1:05Download video MP4
Download video MP3
Similar videos
-
1:05
dr. pal on potential tivozanib-based combinations in rcc
-
1:08
dr. choueiri on the biology of the cabosun trial for rcc
-
0:52
dr. choueiri on the role of cabozantinib in rcc
-
12:31
natural history of patients with local recurrence after nephrectomy for localized rcc
-
3:57
around the world with advanced rcc (part 1): understanding pathways and pathology
-
6:41
pembrolizumab as adjuvant therapy for patients with renal cell carcinoma
-
9:29
keynote-564 study
-
44:53
renal masses: inpatient and outpatient evaluations (and updates in renal cell carcinoma)
-
7:08
genetic profiling in rcc
-
0:53
the role of icis in the adjuvant setting for rcc
-
1:00
dr. vaishampayan on the potential of tivozanib in advanced rcc
-
1:32
dr. mcgregor on the future of cabozantinib in rcc
-
0:35
the latest developments in adjuvant therapy for rcc
-
1:06
dr. choueiri on fda approval of cabozantinib for rcc
-
36:23
adjuvant treatment of rcc dan george, m.d.
-
0:56
dr. mckay on the role of age and gender in advanced rcc outcomes
-
20:55
state of art - management of advanced rcc - dr. nair rajesh
-
14:59
adjuvant treatment of rcc—part 1
-
3:03
adjuvant pembrolizumab improves rcc disease-free survival | toni choueiri
-
1:23:33
fine-tuning the wave of innovation in rcc
-
1:03
dr. mcgregor on the evolving treatment landscape of rcc
-
2:50
mcq on chromophobe rcc | prepladder neet ss